OR52X1P

Across TCGA pan-cancer cohorts, OR52X1P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR52X1P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR52X1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR52X1P expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

STAD, LIHC, and KIRC are the cancer types where OR52X1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.163	0.464	<.001	123	view →
LIHC	OS	Tertile	II,III,IV	0.073	0.720	<.001	72	view →
KIRC	OS	Tertile	II,III,IV	0.504	0.707	.009	57	view →
UCS	OS	Tertile	IV	0.224	0.694	.004	36	view →
GBM	OS	Tertile	All	0.005	0.416	<.001	18	view →
LUAD	DFS	Tertile	II,III,IV	0.809	0.524	.037	12	view →
KIRP	OS	Tertile	II,III,IV	0.199	0.771	.030	9	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
LAML	DFS	Quartile	All	0.419	0.619	.049	2	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR52X1P–STAD (OS)

Open the STAD breakdown →